alzheimer-disease

Documents about alzheimer-disease

• The role of ionotropic glutamate receptors in Alzheimer's disease: A scientometric analysis#5614Europe PMC
• Insight Into the Epigenetics of Alzheimer's Disease: A computational study from Human Interactome#31381Zenodo (CERN)
• The impact of learning about financial compensation on enrollment in Alzheimer's disease longitudinal research.#162235PubMed
• Associations of plasma biomarkers with age in the presenilin-1 E280A autosomal dominant Alzheimer's disease kindred#259841Europe PMC
• The Cellular Mechanisms of Alzheimer's Disease Protection by the PILRA G78R Variant#321492BYU ScholarsArchive
• Does Following the MIND Diet Slow Cognitive Decline and Alzheimer’s Disease?#424421DigitalCommons@USU
• Cognition in Non-Demented Elderly With a Family History of Alzheimer's Disease#433098DigitalCommons@USU
• Studying the Effects of Antihypertensives on Individuals at Risk for Alzheimer's#158073ClinicalTrials.gov
• Diagnostic Performance of Plasma Biomarkers of Alzheimer's Disease Compared With CSF Markers#391041ClinicalTrials.gov
• Translational Feasibility of Curcumin for Treatment of Alzheimer’s Disease: A Critical Appraisal of Clinical Challenges#231310Europe PMC
• Influence of Speech Disfluencies and Prompt Optimization in LLM-Based Alzheimer's Disease Classification#246121DigitalCommons@Kennesaw State University
• Glial Cells in Behavioral and Psychological Symptoms of Alzheimer's Disease#246391Europe PMC
• Translational Feasibility of Curcumin for Treatment of Alzheimer's Disease: A Critical Appraisal of Clinical Challenges#246393Europe PMC
• Assessment of clinical and neuroimaging efficacy of treatment targeting tau pathology in mild cognitive impairment and mild to moderate Alzheimer’s disease with hydromethylthionine mesylate using external control data✰✰✰#123242Europe PMC
• Assessment of clinical and neuroimaging efficacy of treatment targeting tau pathology in mild cognitive impairment and mild to moderate Alzheimer's disease with hydromethylthionine mesylate using external control data#125809Europe PMC
• Olfactory decline tracks central-to-peripheral spread of tau pathology in Alzheimer's disease#120130Europe PMC
• Public Policy Implications of Liability Regimes for Injuries Caused by Persons with Alzheimer's Disease#167575Digital Commons @ University of Georgia School of Law
• CSF IL-6, GDF-15, GFAP and NfL levels in early Alzheimer disease: a pilot study#202760IRIS
• AN INVESTIGATION INTO THE NEUROPROTECTIVE POTENTIAL OF ERGOTHIONEINE IN THE AMYLOID HYPOTHESIS OF ALZHEIMER’S DISEASE#254779ScholarBank@NUS
• Quantitative susceptibility mapping of the brain is associated with inflammatory changes in Alzheimer's disease related areas#333047Europe PMC
• Astrocytes, via RTP801, contribute to cognitive decline by disrupting GABAergic-regulated connectivity and driving neuroinflammation in an Alzheimer's disease mouse model#184965Dipòsit Digital de la Universitat de Barcelona
• Alzheimer's disease knowledge graph enhances knowledge discovery and disease prediction.#247544NCBI PubMed Central
• Plasma GFAP outperforms CSF GFAP in detecting amyloid pathology and is associated with increased risk of clinical progression in early Alzheimer's disease#182053Europe PMC
• Serum amino acid levels are associated with brain hypometabolism in patients across the Alzheimer's disease continuum#5363Europe PMC
• Heterogeneous patterns of cognitive decline in Alzheimer's disease across three domains of cognition#144950HAL (France)
• Screening for Alzheimer's disease in the community using an AI-driven screening platform: design of the PREDICTOM study#182054Europe PMC
• Naphthyl-functionalized acetamide derivatives: Promising agents for cholinesterase inhibition and antioxidant therapy in Alzheimer's disease#197436Repositorio UNAB
• A computational framework to predict the spreading of Alzheimer’s disease#248588Spiral
• Dexmedetomidine Exerts Multi-Level Effects to Ameliorate Alzheimer’s Disease Pathology in the Adult Zebrafish Brain#256625İzmir Yüksek Teknoloji Enstitüsü
• An automated plasma‐based proteotyping immunoassay for APOE ε4 zygosity classification in Alzheimer's disease#274386HAL (France)
• Centralized Review of Alzheimer’s Disease and Related Dementias Biomedical Repositories and Computational Methods#314719Europe PMC
• Blood serum from individuals with Alzheimer’s disease alters microglial phagocytosis in vitro#353989HAL (France)
• Myelin injury and degraded myelin vesicles in Alzheimer’s disease#612114eScholarship
• Alzheimer’s Disease Brain Phenotypes are Age-dependent#5466Europe PMC
• Metrifonate for Alzheimer's disease.#461496NCBI PubMed Central
• Integrating the physical environment into Alzheimer's disease and Alzheimer's disease related dementias research: A Gateway Exposome Coordinating Center (GECC) agenda on gaps and priorities.#125276NCBI PubMed Central
• New Alzheimer’s Disease Diagnostics and Psychological Clinical Perspectives#397098OSF
• The HTT gene influences plasma neurofilament light chain and brain metabolism in prodromal Alzheimer's disease#436342IRIS
• Synthesis, molecular docking, molecular dynamics and DFT studies of new thiazole derivatives as dual cholinesterase inhibitors against alzheimer’s disease#450228Recep Tayyip Erdoğan University Institutional Repository
• Amyloid‐related imaging abnormalities (ARIA) in anti‐amyloid therapies for Alzheimer's disease: An update from the Alzheimer's Association ARIA workgroup#125786Europe PMC
• Amyloid PET imaging in Alzheimer’s disease: a comparison of three radiotracers#612146eScholarship
• Overcoming the blood‒brain barrier: nanomedicine strategies for targeted delivery and multimodal therapy in Alzheimer's disease#4528Europe PMC
• Signaling cascades shape functional subpopulations of cortical astrocytes in male wild-type mice and APP/PS1dE9 Alzheimer’s disease model#14159HAL (France)
• Divergent patterns of cognitive decline in preclinical Alzheimer's disease: Implications for secondary prevention trials#125782Europe PMC
• Neuroimaging in dementia and Alzheimer's disease: Current protocols and practice in the Republic of Ireland#186496Research Repository UCD
• The effect of canagliflozin on hippocampal dendrite morphology in a model of Alzheimer's disease induced by intracerebroventricular injection of streptozotocin#312253Muğla Sıtkı Koçman University Institutional Repository
• Detecting Alzheimer’s Disease through Chinese Speech: A Contrast of Manual and Automatic Linguistic Feature Extraction#368857OSF
• Social exposome and brain health outcomes of dementia across Latin America#385632Repositorio Universidad del Desarrollo
• Solvation-Guided Design of Fluorescent Probes for Discrimination of Amyloids#492062eScholarship
• Towards pharmacological prevention of Alzheimer disease.#258085NCBI PubMed Central